IndiaOne Finance - Company Dashboard

Governance Classic Home

Gufic Biosciences LtdPharmaceuticalsINE742B01025Consolidated₹435.60+9.45 (+2.22%)Jun-26

Valuation

Market Cap₹4.37K Cr

TTM PE59.56x

Forward PE57.98x

PEG4.14

Book Value₹66.31

P/B6.58x

TTM EPS₹7.32

Fwd EPS₹7.52

TTM Revenue₹981.11 Cr

TTM PAT₹73.45 Cr

TTM EBITDA₹164.65 Cr

TTM EBIT₹133.83 Cr

Last Qtr PAT₹22.31 Cr

Last Qtr EBITDA₹46.61 Cr

Last Qtr EBIT₹38.90 Cr

Profitability

ROE11.05%

ROCE12.81%

TTM NPM7.49%

TTM EBITDA %16.78%

Curr OPM8.54%

Last OPM8.74%

Curr NPM—

Last NPM—

Curr EPS₹2.22

Last EPS₹2.18

Balance sheet

Equity₹10.03 Cr

Reserve₹654.92 Cr

Total Debt₹397.17 Cr

D/E0.60x

Interest %41.77%

Curr Interest₹9.32 Cr

Price / range

Close₹436.00

vs 52W High—

vs 52W Low—

MA50—

MA200—

Returns

1D+2.47%

1W+2.68%

1M+3.55%

3M+22.00%

6M+45.01%

1Y+19.96%

2Y+9.66%

3Y+48.48%

5Y+112.84%

Diwali+28.24%

Sector peers — Pharmaceuticals

Company	Close	Mkt Cap	TTM P/E	ROE
SUNPHARMA	1837.30	₹4.41L Cr	36.45	14.50%
DIVISLAB	9375.00	₹2.49L Cr	85.06	17.45%
TORNTPHARM	4840.00	₹1.84L Cr	77.32	25.70%
ZYDUSLIFE	1160.00	₹1.16L Cr	25.85	16.94%
CIPLA	1394.50	₹1.13L Cr	33.41	9.75%
LAURUSLABS	1954.00	₹1.06L Cr	96.45	20.58%
AUROPHARMA	1734.00	₹99.77K Cr	27.09	9.79%
DRREDDY	1185.00	₹98.91K Cr	30.63	8.40%

Financial Results

Quarterly and yearly P&L · YoY % on Revenue, Total Income, Expenditure, EBITDA, EBIT, PBT, Net Profit and EPS

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	260.82+14.9%	252.05	231.09	230.42	226.91	940.48
Other Income	0.46	-1.20	0.79	2.09	0.89	2.58
Total Income	261.28+14.7%	250.86	231.89	232.51	227.81	943.06
Interest	9.32	9.44	8.36	9.59	9.23	36.61
Expenditure	-231.11-9.3%	-223.23	-210.84	-211.98	-211.53	-857.57
PBDT	0	0	0	0	0	0
EBITDA	46.74+44.6%	45.91	36.30	35.80	32.33	150.35
Depreciation	-7.71	-7.65	-7.69	-7.77	-7.72	-30.83
EBIT	39.03+58.6%	38.26	28.61	28.03	24.61	119.52
PBT	30.16+85.3%	27.63	21.05	20.53	16.28	85.49
Tax	-7.70	-7.05	-5.49	-5.59	-4.20	-22.34
Equity	10.03	10.03	0	0	10.03	10.03
OPM	11.54	11.01	9.11	8.91	7.15	9.06
Net Profit	22.46+86.1%	20.57	15.56	14.94	12.07	63.15
NPM	8.60	8.20	6.73	6.48	5.30	6.70
EPS	2.24+86.7%	2.05	1.55	1.49	1.20	6.30

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24	FY 22-23	FY 21-22	FY 20-21
Revenue	940.48+14.7%	819.81+1.6%	806.67+16.8%	690.62-11.4%	779.16+59.8%	487.70
Other Income	2.58	3.62	2.18	2.57	3.10	3.73
Total Income	943.06+14.5%	823.42+1.8%	808.84+16.7%	693.20-11.4%	782.26+59.2%	491.43
Expenditure	-857.57-17.6%	-728.99-5.2%	-693.17-18.2%	-586.47+10.5%	-655.42-51.1%	-433.72
Interest	-36.61	-23.11	-15.36	-8.22	-4.85	-13.63
PBDT	0	0	0	0	0	0
EBITDA	150.35+11.4%	134.99-7.5%	145.88+8.3%	134.65-7.6%	145.72+73.6%	83.92
Depreciation	-30.83	-21.06	-17.02	-22.28	-17.13	-16.31
EBIT	119.52+4.9%	113.93-11.6%	128.86+14.7%	112.37-12.6%	128.59+90.2%	67.61
PBT	85.49-9.5%	94.43-18.4%	115.67+8.4%	106.72-15.9%	126.84+119.8%	57.71
Tax	-22.34	-24.49	-29.54	-27.02	-31	-13.48
Equity	10.03	10.03	0	0	0	0
OPM (%)	9.06	11.47	14.00	15.00	16.00	12.00
Net Profit	63.15-9.7%	69.93-18.8%	86.14+8.1%	79.71-16.8%	95.84+116.7%	44.23
NPM (%)	6.70	8.49	11.00	11.00	12.00	9.00
EPS (Rs)	6.30-9.6%	6.97-20.3%	8.74+6.3%	8.22-16.9%	9.89+116.9%	4.56
CEPS	6.30	6.97	8.74	8.22	9.89	4.56

Metric	Jun-26	Mar-26	Dec-25	Sep-25	Jun-25	FY25-26
Revenue	260.82+16.6%	251.82	231.41	237.06	223.72	944.01
Other Income	0.46	-1.17	0.79	2.12	0.93	2.66
Total Income	261.28+16.3%	250.65	232.20	239.17	224.65	946.66
Interest	9.32	9.44	8.36	9.59	9.23	36.61
Expenditure	-231.24-11.5%	-221.70	-214.48	-216.57	-207.37	-860.12
PBDT	0	0	0	0	0	0
EBITDA	46.61+40.0%	47.21	32.98	37.85	33.30	151.33
Depreciation	-7.71	-7.65	-7.69	-7.77	-7.72	-30.83
EBIT	38.90+52.1%	39.56	25.29	30.08	25.58	120.50
PBT	30.04+73.9%	28.95	17.72	22.60	17.27	86.55
Tax	-7.73	-7.05	-5.30	-5.78	-4.20	-22.34
Equity	10.03	10.03	0	0	10.03	10.03
OPM	11.50	11.55	7.63	9.45	7.69	9.14
Net Profit	22.31+70.7%	21.90	12.42	16.82	13.07	64.21
NPM	8.54	8.74	5.35	7.03	5.82	6.78
EPS	2.22+70.8%	2.18	1.24	1.68	1.30	6.40

Yearly results

Last 6 financial years · YoY % vs previous FY

Metric	FY 25-26	FY 24-25	FY 23-24
Revenue	944.01+15.2%	819.81+1.6%	806.67
Other Income	2.66	3.63	2.18
Total Income	946.66+15.0%	823.43+1.8%	808.84
Expenditure	-860.12-17.9%	-729.29-5.2%	-693.17
Interest	-36.61	-23.11	-15.36
PBDT	0	0	0
EBITDA	151.33+12.4%	134.69-7.7%	145.88
Depreciation	-30.83	-21.06	-17.02
EBIT	120.50+6.0%	113.63-11.8%	128.86
PBT	86.55-8.1%	94.14-18.6%	115.67
Tax	-22.34	-24.49	-29.54
Equity	10.03	10.03	0
OPM (%)	9.14	11.43	14.30
Net Profit	64.21-7.8%	69.65-19.1%	86.14
NPM (%)	6.78	8.46	10.65
EPS (Rs)	6.40-7.9%	6.95-20.5%	8.74
CEPS	6.40	6.95	8.74

Corporate Actions

Dividends, bonus issues, and stock splits

Dividend

Year	Type	Amount	Ex-Date
2026	Final Dividend	0.1	28 Aug 2026
2025	Final Dividend	0.1	22 Sep 2025
2024	Final Dividend	0.1	18 Sep 2024
2024	Final Dividend	0.1	17 Sep 2024
2023	Final Dividend	0.1	21 Sep 2023
2022	Final Dividend	0.1	24 Aug 2022
2021	Final Dividend	0.1	09 Sep 2021
2020	Final Dividend	0.05	03 Nov 2020
2019	Final Dividend	0.05	20 Sep 2019
2018	Final Dividend	0.05	19 Sep 2018
2017	Final Dividend	0.05	28 Aug 2017
2016	Final Dividend	0.05	19 Sep 2016
2015	Final Dividend	0.05	22 Sep 2015
2014	Final Dividend	0.05	18 Sep 2014
2013	Final Dividend	0.05	02 Sep 2013
2012	Final Dividend	0.05	16 Aug 2012
2011	Final Dividend	0.05	16 Sep 2011
2010	Final Dividend	0.05	20 Sep 2010
2009	Final Dividend	0.05	17 Sep 2009
2008	Final Dividend	0.05	11 Dec 2008
2008	Final Dividend	0.05	19 Mar 2008

Bonus

No bonus history.

Split

No split history.

Financial Results

Standalone

Yearly results

Yearly

Consolidated

Yearly results

Yearly

Corporate Actions

Dividend

Bonus

Split